Aeterna Zentaris Inc (AEZS.O)
26 Jun 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|65||2014||Chairman of the Board, President, Chief Executive Officer|
|2007||Chief Financial Officer, Senior Vice President|
|62||2014||Senior Vice President, Chief Administrative Officer, General Counsel|
|2014||Senior Vice President, Chief Scientific Officer, Chief Medical Officer|
|2013||Chief Commercial Officer, Senior Vice President|
- BRIEF-Aeterna Zentaris says ZoptEC Phase 3 clinical study of Zoptrex did not achieve primary endpoint
- BRIEF-Aeterna Zentaris intends to file NDA with respect to Macrilen in Q3
- BRIEF-Aeterna Zentaris files for common shares stock shelf offering of up to $50 mln
- BRIEF-Aeterna Zentaris qtrly loss per share $0.71
- BRIEF-Aeterna Zentaris announces EMA pediatric committee agreement